Cite
Abstract P5-12-17: Prognostic and predictive value of serum level of vascular endothelial growth factor-A in metastatic breast cancer patients treated with bevacizumab plus paclitaxel
MLA
Shigenori Nagai, et al. “Abstract P5-12-17: Prognostic and Predictive Value of Serum Level of Vascular Endothelial Growth Factor-A in Metastatic Breast Cancer Patients Treated with Bevacizumab plus Paclitaxel.” Cancer Research, vol. 79, Feb. 2019, pp. P5-12. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........f85c2a05fccc0c97d278e0d6c79c33da&authtype=sso&custid=ns315887.
APA
Shigenori Nagai, Kenichi Inoue, K Kubo, Yuji Hayashi, A. Sato, Y Yamada, X Wang, K Takai, Hiroshi Matsumoto, Katsunori Tozuka, & M Tsuboi. (2019). Abstract P5-12-17: Prognostic and predictive value of serum level of vascular endothelial growth factor-A in metastatic breast cancer patients treated with bevacizumab plus paclitaxel. Cancer Research, 79, P5-12.
Chicago
Shigenori Nagai, Kenichi Inoue, K Kubo, Yuji Hayashi, A. Sato, Y Yamada, X Wang, et al. 2019. “Abstract P5-12-17: Prognostic and Predictive Value of Serum Level of Vascular Endothelial Growth Factor-A in Metastatic Breast Cancer Patients Treated with Bevacizumab plus Paclitaxel.” Cancer Research 79 (February): P5-12. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........f85c2a05fccc0c97d278e0d6c79c33da&authtype=sso&custid=ns315887.